Stock Research: Towa Pharmaceutical

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Towa Pharmaceutical

TSE:4553 JP3623150004
96
  • Value
    100
  • Growth
    60
  • Safety
    Safety
    49
  • Combined
    88
  • Sentiment
    84
  • 360° View
    360° View
    96
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Towa Pharmaceutical Co Ltd manufactures and sells pharmaceuticals, primarily generic drugs, and is also involved in the research and outsourced manufacture of active pharmaceutical ingredients and soft capsules, as well as the planning, development, and contract manufacturing of health foods, general foods, and miscellaneous goods. The company is based in Japan. In the last fiscal year, the company had a market cap of $1092 millions, profits of $632 millions, revenue of $1731 millions, and 4788 employees.

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
100 96 100 99
Growth
60 26 63 79
Safety
Safety
49 47 37 63
Sentiment
84 68 45 37
360° View
360° View
96 72 73 91
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
48 60 63 46
Opinions Change
92 50 79 50
Pro Holdings
n/a 66 48 53
Market Pulse
60 52 11 28
Sentiment
84 68 45 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
100 96 100 99
Growth
60 26 63 79
Safety Safety
49 47 37 63
Combined
88 67 88 98
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
97 97 90 100
Price vs. Earnings (P/E)
95 97 97 100
Price vs. Book (P/B)
88 90 89 82
Dividend Yield
67 58 76 81
Value
100 96 100 99
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
46 45 46 72
Profit Growth
32 30 96 55
Capital Growth
66 4 7 5
Stock Returns
86 62 63 100
Growth
60 26 63 79
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
5 3 1 10
Refinancing
96 98 99 87
Liquidity
45 37 32 70
Safety Safety
49 47 37 63

Similar Stocks

Discover high‑ranked alternatives to Towa Pharmaceutical and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

Megmilk Snow Brand

TSE:2270
Country: Japan
Industry: Packaged Foods & Meats
Size: Medium
Full Stock Analysis

Alfresa Holdings

TSE:2784
Country: Japan
Industry: Health Care Distributors
Size: Large
Full Stock Analysis

Kyudenko

TSE:1959
Country: Japan
Industry: Construction & Engineering
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This is a high-quality, high-growth stock with positive sentiment. However, the financing is on the riskier side. It is best for a growth-focused investor willing to accept higher financial risk for potentially higher shareholder returns.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: